Cargando…

Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide

In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly spread throughout China. Since the outbreak of the pandemic, in addition to the well-known COVID-19 symptoms, various neurological symptoms have been also described in patients with COVID-19. Here, we report an unusua...

Descripción completa

Detalles Bibliográficos
Autores principales: Yetkin, Mehmet Fatih, Yetkin, Nur Aleyna, Akcakoyunlu, Merve, Mirza, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856853/
https://www.ncbi.nlm.nih.gov/pubmed/33534122
http://dx.doi.org/10.1007/s10072-021-05097-2
_version_ 1783646326736551936
author Yetkin, Mehmet Fatih
Yetkin, Nur Aleyna
Akcakoyunlu, Merve
Mirza, Meral
author_facet Yetkin, Mehmet Fatih
Yetkin, Nur Aleyna
Akcakoyunlu, Merve
Mirza, Meral
author_sort Yetkin, Mehmet Fatih
collection PubMed
description In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly spread throughout China. Since the outbreak of the pandemic, in addition to the well-known COVID-19 symptoms, various neurological symptoms have been also described in patients with COVID-19. Here, we report an unusual presentation of COVID-19 infection in a teriflunomide-treated individual with multiple sclerosis (MS) who did not interrupt teriflunomide treatment during the infection. The course of the infection was mild in this case as in other reported teriflunomide-treated individuals with COVID-19. COVID-19’s presentation may be unusual in people with MS (pwMS). It can also be concluded that teriflunomide may be considered a safe disease-modifying treatment option during the pandemic.
format Online
Article
Text
id pubmed-7856853
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-78568532021-02-03 Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide Yetkin, Mehmet Fatih Yetkin, Nur Aleyna Akcakoyunlu, Merve Mirza, Meral Neurol Sci Covid-19 In December 2019, coronavirus disease 2019 (COVID-19) emerged in Wuhan and rapidly spread throughout China. Since the outbreak of the pandemic, in addition to the well-known COVID-19 symptoms, various neurological symptoms have been also described in patients with COVID-19. Here, we report an unusual presentation of COVID-19 infection in a teriflunomide-treated individual with multiple sclerosis (MS) who did not interrupt teriflunomide treatment during the infection. The course of the infection was mild in this case as in other reported teriflunomide-treated individuals with COVID-19. COVID-19’s presentation may be unusual in people with MS (pwMS). It can also be concluded that teriflunomide may be considered a safe disease-modifying treatment option during the pandemic. Springer International Publishing 2021-02-03 2021 /pmc/articles/PMC7856853/ /pubmed/33534122 http://dx.doi.org/10.1007/s10072-021-05097-2 Text en © Fondazione Società Italiana di Neurologia 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Covid-19
Yetkin, Mehmet Fatih
Yetkin, Nur Aleyna
Akcakoyunlu, Merve
Mirza, Meral
Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
title Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
title_full Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
title_fullStr Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
title_full_unstemmed Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
title_short Transient monocular visual impairment as an initial symptom of COVID-19 infection in an individual with multiple sclerosis receiving teriflunomide
title_sort transient monocular visual impairment as an initial symptom of covid-19 infection in an individual with multiple sclerosis receiving teriflunomide
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856853/
https://www.ncbi.nlm.nih.gov/pubmed/33534122
http://dx.doi.org/10.1007/s10072-021-05097-2
work_keys_str_mv AT yetkinmehmetfatih transientmonocularvisualimpairmentasaninitialsymptomofcovid19infectioninanindividualwithmultiplesclerosisreceivingteriflunomide
AT yetkinnuraleyna transientmonocularvisualimpairmentasaninitialsymptomofcovid19infectioninanindividualwithmultiplesclerosisreceivingteriflunomide
AT akcakoyunlumerve transientmonocularvisualimpairmentasaninitialsymptomofcovid19infectioninanindividualwithmultiplesclerosisreceivingteriflunomide
AT mirzameral transientmonocularvisualimpairmentasaninitialsymptomofcovid19infectioninanindividualwithmultiplesclerosisreceivingteriflunomide